<!doctype html><html lang=en><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1,shrink-to-fit=no"><title>Chinese biotech firm Clover signs deal to make millions of Covid-19 vaccines for Covax Facility -</title><meta name=robots content="index,follow,noarchive"><meta name=description content="Gavi also had the option to buy up to 350 million doses next year and vaccines that were updated for variants in the future, it said in a statement.
China’s Sinovac set to start making Covid-19 jabs at Egyptian plants
“The pandemic continues to evolve, and to be best prepared, Covax’s actively managed, diverse portfolio will be critical to meeting countries’ needs, and protecting against risks such as regulatory delays, variants, and supply constraints,” said Seth Berkley, Gavi’s chief executive."><meta name=author content="Reinaldo Massengill"><link rel="preload stylesheet" as=style href=https://assets.cdnweb.info/hugo/paper/css/app.css><link rel="preload stylesheet" as=style href=https://assets.cdnweb.info/hugo/paper/css/an-old-hope.min.css><script defer src=https://assets.cdnweb.info/hugo/paper/js/highlight.min.js onload=hljs.initHighlightingOnLoad()></script>
<link rel=preload as=image href=./theme.png><link rel=icon href=./favicon.ico><link rel=apple-touch-icon href=./apple-touch-icon.png><meta name=generator content="Hugo 0.98.0"><meta property="og:title" content="Chinese biotech firm Clover signs deal to make millions of Covid-19 vaccines for Covax Facility"><meta property="og:description" content="Gavi also had the option to buy up to 350 million doses next year and vaccines that were updated for variants in the future, it said in a statement. Chinas Sinovac set to start making Covid-19 jabs at Egyptian plants"><meta property="og:type" content="article"><meta property="og:url" content="/chinese-biotech-firm-clover-signs-deal-make-millions-covid-19.html"><meta property="article:section" content="post"><meta property="article:published_time" content="2024-04-14T00:00:00+00:00"><meta property="article:modified_time" content="2024-04-14T00:00:00+00:00"><meta itemprop=name content="Chinese biotech firm Clover signs deal to make millions of Covid-19 vaccines for Covax Facility"><meta itemprop=description content="Gavi also had the option to buy up to 350 million doses next year and vaccines that were updated for variants in the future, it said in a statement. Chinas Sinovac set to start making Covid-19 jabs at Egyptian plants"><meta itemprop=datePublished content="2024-04-14T00:00:00+00:00"><meta itemprop=dateModified content="2024-04-14T00:00:00+00:00"><meta itemprop=wordCount content="461"><meta itemprop=keywords content><meta name=twitter:card content="summary"><meta name=twitter:title content="Chinese biotech firm Clover signs deal to make millions of Covid-19 vaccines for Covax Facility"><meta name=twitter:description content="Gavi also had the option to buy up to 350 million doses next year and vaccines that were updated for variants in the future, it said in a statement. Chinas Sinovac set to start making Covid-19 jabs at Egyptian plants"></head><body class=not-ready data-menu=true><header class=header><p class=logo><a class=site-name href=./index.html>VivaSync</a><a class=btn-dark></a></p><script>let bodyClx=document.body.classList,btnDark=document.querySelector(".btn-dark"),sysDark=window.matchMedia("(prefers-color-scheme: dark)"),darkVal=localStorage.getItem("dark"),setDark=e=>{bodyClx[e?"add":"remove"]("dark"),localStorage.setItem("dark",e?"yes":"no")};setDark(darkVal?darkVal==="yes":sysDark.matches),requestAnimationFrame(()=>bodyClx.remove("not-ready")),btnDark.addEventListener("click",()=>setDark(!bodyClx.contains("dark"))),sysDark.addEventListener("change",e=>setDark(e.matches))</script><nav class=menu><a href=./sitemap.xml>Sitemap</a></nav></header><main class=main><article class=post-single><header class=post-title><p><time>Apr 14, 2024</time>
<span>Reinaldo Massengill</span></p><h1>Chinese biotech firm Clover signs deal to make millions of Covid-19 vaccines for Covax Facility</h1></header><section class=post-content><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Gavi also had the option to buy up to 350 million doses next year and vaccines that were updated for variants in the future, it said in a statement.</p><h3 type=h3 data-qa=Component-Component class="e14khtrb0 css-17x7qa9 e793b7w1"><a class="link-text css-e0dnmk ef1hf1w0" href=# data-qa=BaseLink-renderAnchor-StyledAnchor><p><span data-qa=DigitalArchiveLink-TitleText class="css-66qo9a eeeqn932">China’s Sinovac set to start making Covid-19 jabs at Egyptian plants</span></p></a></h3><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">“The pandemic continues to evolve, and to be best prepared, Covax’s actively managed, diverse portfolio will be critical to meeting countries’ needs, and protecting against risks such as regulatory delays, variants, and supply constraints,” said Seth Berkley, Gavi’s chief executive. “Today’s agreement with Clover Biopharmaceuticals is yet another important step in that direction.”</p>It is the first Chinese-made <a class="d8-auto-link euc41pk0 e13op9j60 e1qbu6wp1 css-jgjyn2 ef1hf1w0" href=# data-qa=BaseLink-renderAnchor-StyledAnchor><span data-qa=Component-Text class="css-0 e1qbu6wp0">Covid-19 vaccine</span></a> that has been officially named as a supplier to the WHO-backed Covax Facility. Earlier this month, Sinopharm, which gained WHO emergency use listing for its vaccine in May, produced 10 million doses to be donated to Covax.<p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Another Chinese vaccine producer Sinovac, which obtained emergency use listing earlier this month, is still in negotiations. China’s foreign ministry has previously said that several firms are talking to Gavi, and the ministry supports such “communication and cooperation”.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">The Clover vaccine targets a part of the coronavirus’s spike protein that helps bind it to the host cell. Small-scale phase 1 human trials were held in Perth, Western Australia last June and reported encouraging results in a paper published in The Lancet in February.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">In March the company announced that larger scale, late-stage trials, involving more than 22,000 participants in Latin America, Asia, Europe and Africa had started.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">CEPI, the Coalition for Epidemic Preparedness Innovations which manages Covid-19 vaccine research and development for Covax, funded the trials for Clover.</p><h3 type=h3 data-qa=Component-Component class="e14khtrb0 css-17x7qa9 e793b7w1"><a class="link-text css-e0dnmk ef1hf1w0" href=# data-qa=BaseLink-renderAnchor-StyledAnchor><p><span data-qa=DigitalArchiveLink-TitleText class="css-66qo9a eeeqn932">Chinese firm puts Covid-19 vaccine to landmark test in New Zealand</span></p></a></h3><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Joshua Liang Guo, Clover’s chief executive, said the company was “grateful for the support from Gavi, CEPI and other Covax partners in our joint pursuit of supporting global equitable access of Covid-19 vaccines and helping protect at-risk groups in participating countries”.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Clover said it was expecting to receive a significant upfront payment, a payment upon producing positive phase 2 and 3 data, then additional advance payments upon Gavi exercising options for doses to be delivered next year.</p><img data-qa=BaseImage-handleRenderImage-StyledImage src=https://cdn.statically.io/img/cdn.i-scmp.com/sites/default/files/styles/wide_landscape/public/d8/video/thumbnail/2021/06/21/china_vaccination_web_clear.jpg style=margin:auto;display:block;text-align:center><p data-qa=SCMPYoutubeVideoPreview-PreviewDuration class="css-dkee4u eaw92su1">01:06</p><p data-qa=SCMPYoutubeVideoPreview-PreviewTitle class="css-1ajvbe4 eaw92su2">China’s Covid-19 vaccination drive hits 1 billion mark</p><p>China’s Covid-19 vaccination drive hits 1 billion mark</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">In March, Liang told People’s Daily that the company’s production facility in eastern Zhejiang province could make more than a billion doses a year.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Gavi is overseeing a portfolio of vaccines for the Covax Facility and had already signed agreements with eight vaccine manufacturers, including AstraZeneca-Oxford, Janssen, Moderna, Novavax and Pfizer-BioNTech. Its ultimate intention is to have 10 to 12 vaccines in its portfolio for use in different situations.</p><p>This article appeared in the South China Morning Post print edition as: Chinese start-up to make 414 million jabs for Covax Facility</p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmivp6x7tK%2FMqWWcp51ku6bD0miaoaGelny0r8iepZydX5a%2FtbXCpZxoa2FohnSBkWiaoaGemsCmecGipq2dk516p7XRpmScpJ%2BrsrN50qKep6tdmbKiuIymmKSdXaK2rbjIqKWsZZOkw6qwjGpw</p></section><nav class=post-nav><a class=prev href=./the-exorcist-movie-trivia.html><span>←</span><span>5 Freaky Facts About &amp;quot;The Exorcist&amp;quot;</span></a>
<a class=next href=./d-h-lawrence-this-is-the-very-worst-wickedness-that-we-refuse-to-acknowledge-the-passionate-evil-that-is-in-us-this-makes-us-secret-and-rotten.html><span>D. H. Lawrence: 'This is the very worst wickedness, that we refuse to acknowledge the passionate evi</span><span>→</span></a></nav></article></main><footer class=footer><p>&copy; 2024 <a href=./></a></p><p>Powered by <a href=https://gohugo.io/ rel=noopener target=_blank>Hugo️️</a>️</p></footer><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/floating.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/tracking_server_6.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>